MAP2K5 and breast carcinoma: Together, these data are in line with previous studies which have investigated theMEK5 signaling axis in breast cancer outcomes using the Kaplan Meier analyses andstrengthen the importance of MEK5 signaling in breast cancer progression and outcomes.